ISTHMUS PARTNERS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ISTHMUS PARTNERS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2015$429,000
+8.3%
13,300
+8.6%
0.15%
+3.4%
Q3 2015$396,000
-19.8%
12,244
+2.6%
0.14%
-11.0%
Q2 2015$494,000
-2.8%
11,939
+5.6%
0.16%
-5.2%
Q1 2015$508,000
+25.1%
11,305
+4.1%
0.17%
+24.6%
Q4 2014$406,00010,8590.14%
Other shareholders
HAEMONETICS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders